FIGURE 3. Cumulative disease-free survival (A) and overall survival (B) of patients with stage II disease in the anterior approach group (18 patients) and the conventional approach group (25 patients).
FIGURE 3. Cumulative disease-free survival (A) and overall survival (B) of patients with stage II disease in the anterior approach group (18 patients) and the conventional approach group (25 patients).